Nxera Pharma

About the Company

Nxera Pharma (formerly Sosei Heptares) is a technology-driven biopharmaceutical company focused on developing innovative specialty medicines to address unmet medical needs in Japan and globally.

The company has several products already commercialized in Japan and is advancing a robust pipeline of over 30 active programs, spanning from early discovery to late-stage clinical development. These programs, pursued both independently and through partnerships with leading pharmaceutical and biotech companies, target key therapeutic areas such as neurology, gastrointestinal and immunological diseases, metabolic disorders, and rare conditions. Central to Nxera Pharma’s approach is its proprietary GPCR-focused, structure-based drug discovery platform, “NxWave,” which underpins a sustainable pipeline of potential best-in-class or first-in-class candidates.